{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2020-D-1136\" sorted by posted_date descending", "rows": [["FDA-2020-D-1136-0085", "FDA", "FDA-2020-D-1136", "Development of Monoclonal Antibody Products Targeting SARS-CoV-2 for Emergency Use Authorization", "Other", "Guidance", "2023-12-22T05:00:00Z", 2023, 12, "2023-12-22T05:00:00Z", null, "2024-11-12T06:25:32Z", null, 1, 0, "090000648634e5c5"], ["FDA-2020-D-1136-0084", "FDA", "FDA-2020-D-1136", "Development of Monoclonal Antibody Products Targeting SARS\u2013CoV\u20132 for\nEmergency Use Authorization; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2023-12-21T05:00:00Z", 2023, 12, null, null, "2023-12-21T16:06:18Z", "2023-28092", 0, 0, "090000648634e184"], ["FDA-2020-D-1136-0083", "FDA", "FDA-2020-D-1136", "Food and Drug Administration; Center of Drug Evaluation and Research Guidance Documents Related to\nCoronavirus Disease 2019, Expiration", "Notice", "Withdrawal", "2023-10-19T04:00:00Z", 2023, 10, "2023-10-19T04:00:00Z", null, "2023-10-19T13:20:17Z", "2023-23071", 0, 0, "090000648610bf60"], ["FDA-2020-D-1136-0082", "FDA", "FDA-2020-D-1136", "Guidance Documents Related to Coronavirus Disease 2019 (COVID\u201319)", "Notice", "General Notice", "2023-03-13T04:00:00Z", 2023, 3, "2023-03-13T04:00:00Z", null, "2023-03-13T14:28:59Z", "2023-05094", 0, 0, "090000648579bdb9"], ["FDA-2020-D-1136-0081", "FDA", "FDA-2020-D-1136", "Temporary Policy on Repackaging or Combining Propofol Drug Products During the COVID\u201319 Public Health Emergency; Withdrawal of Guidance", "Notice", "Withdrawal", "2023-02-10T05:00:00Z", 2023, 2, "2023-02-10T05:00:00Z", null, "2023-02-10T15:41:04Z", "2023-02809", 0, 0, "0900006485653eb7"], ["FDA-2020-D-1136-0079", "FDA", "FDA-2020-D-1136", "Guidance Documents Related to Coronavirus Disease 2019; Availability", "Notice", "Notice of Availability", "2022-03-04T05:00:00Z", 2022, 3, "2022-03-04T05:00:00Z", null, "2023-05-12T20:07:30Z", "2022-04637", 0, 0, "0900006484fb7be1"], ["FDA-2020-D-1136-0077", "FDA", "FDA-2020-D-1136", "COVID-19 Public Health Emergency: Policy on COVID-19-Related Sanitation Tunnels; Guidance for Industry and Investigators", "Other", "Guidance", "2022-02-08T05:00:00Z", 2022, 2, "2022-02-08T05:00:00Z", "2023-05-12T03:59:59Z", "2023-05-08T17:01:37Z", null, 0, 0, "0900006484f5e283"], ["FDA-2020-D-1136-0075", "FDA", "FDA-2020-D-1136", "Guidance Documents Related to\nCoronavirus Disease 2019; Availability", "Notice", "Notice of Availability", "2021-10-06T04:00:00Z", 2021, 10, "2021-10-06T04:00:00Z", null, "2023-05-12T20:07:03Z", "2021-21798", 0, 0, "0900006484dbc502"], ["FDA-2020-D-1136-0074", "FDA", "FDA-2020-D-1136", "Development of Abbreviated New Drug Applications During the COVID-19 Pandemic \u2013 Questions and Answers; Guidance for Industry", "Other", "Guidance", "2021-09-08T04:00:00Z", 2021, 9, "2021-09-08T04:00:00Z", "2023-05-12T03:59:59Z", "2023-05-08T18:53:09Z", null, 0, 0, "0900006484d5f1ce"], ["FDA-2020-D-1136-0073", "FDA", "FDA-2020-D-1136", "Guidance Documents Related to Coronavirus Disease 2019; Availability", "Notice", "Notice of Availability", "2021-07-23T04:00:00Z", 2021, 7, "2021-07-23T04:00:00Z", null, "2023-05-12T20:06:35Z", "2021-15649", 0, 0, "0900006484c097c2"], ["FDA-2020-D-1136-0066", "FDA", "FDA-2020-D-1136", "Guidance: Documents Related to Coronavirus Disease 2019; Availability", "Notice", "Notice of Availability", "2021-05-27T04:00:00Z", 2021, 5, "2021-05-27T04:00:00Z", null, "2023-05-12T20:06:17Z", "2021-11217", 0, 0, "0900006484b3ca2f"], ["FDA-2020-D-1136-0062", "FDA", "FDA-2020-D-1136", "Guidance Documents Related to  Coronavirus Disease 2019; Availability", "Notice", "Notice of Availability", "2021-04-26T04:00:00Z", 2021, 4, "2021-04-26T04:00:00Z", null, "2024-11-06T23:46:13Z", "2021-08474", 1, 0, "0900006484ab6bbf"], ["FDA-2020-D-1136-0057", "FDA", "FDA-2020-D-1136", "Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities During the \nCOVID-19 Public Health Emergency; Guidance for Industry", "Other", "Guidance", "2021-04-14T04:00:00Z", 2021, 4, "2021-04-14T04:00:00Z", null, "2024-11-06T23:47:11Z", null, 1, 0, "0900006484aa70cf"], ["FDA-2020-D-1136-0056", "FDA", "FDA-2020-D-1136", "Development of Abbreviated New Drug Applications During the COVID-19 Pandemic \u2013 Questions and Answers - Guidance for Industry - April 2021\nU.S. Department of Health and Human Services\nFood and Drug Administration\nCenter for", "Other", "Guidance", "2021-04-07T04:00:00Z", 2021, 4, "2021-04-07T04:00:00Z", "2023-05-12T03:59:59Z", "2023-05-08T18:53:55Z", null, 0, 0, "0900006484a9f1b6"], ["FDA-2020-D-1136-0051", "FDA", "FDA-2020-D-1136", "COVID-19 Container Closure System and Component Changes: Glass Vials and Stoppers Guidance for Industry March 2021", "Other", "Guidance", "2021-03-05T05:00:00Z", 2021, 3, "2021-03-05T05:00:00Z", "2021-03-05T04:59:59Z", "2024-11-12T23:30:07Z", null, 1, 0, "0900006484a60779"], ["FDA-2020-D-1136-0050", "FDA", "FDA-2020-D-1136", "Development of Monoclonal Antibody Products Targeting SARS-CoV-2, Including Addressing the Impact of Emerging Variants, During the COVID-19 Public Health Emergency - Guidance for Industry - February 2021", "Other", "Guidance", "2021-02-22T05:00:00Z", 2021, 2, "2021-02-22T05:00:00Z", null, "2024-11-12T23:30:16Z", null, 1, 0, "0900006484a459a4"], ["FDA-2020-D-1136-0049", "FDA", "FDA-2020-D-1136", "Guidance Documents Related to Coronavirus Disease 2019; Availability", "Notice", "Notice of Availability", "2021-02-19T05:00:00Z", 2021, 2, "2021-02-19T05:00:00Z", null, "2024-11-12T23:27:55Z", "2021-03421", 1, 0, "0900006484a42ed9"], ["FDA-2020-D-1136-0047", "FDA", "FDA-2020-D-1136", "COVID-19: Potency Assay Considerations for Monoclonal Antibodies and Other Therapeutic Proteins  Targeting SARS-CoV-2 Infectivity; Guidance for Industry", "Other", "Guidance", "2021-01-22T05:00:00Z", 2021, 1, "2021-01-22T05:00:00Z", null, "2024-11-06T23:44:17Z", null, 1, 0, "09000064849fccda"], ["FDA-2020-D-1136-0046", "FDA", "FDA-2020-D-1136", "Protecting Participants in Bioequivalence Studies for Abbreviated New Drug Applications During the COVID-19 Public Health Emergency Guidance for Industry", "Other", "Guidance", "2021-01-19T05:00:00Z", 2021, 1, "2021-01-19T05:00:00Z", "2023-05-12T03:59:59Z", "2023-05-08T18:56:13Z", null, 0, 0, "09000064849f89c5"], ["FDA-2020-D-1136-0044", "FDA", "FDA-2020-D-1136", "Review Timelines for Applicant Responses to Complete Response Letters When a Facility Assessment Is Needed During the COVID-19 Public Health Emergency Guidance for Industry", "Other", "Guidance", "2020-12-23T05:00:00Z", 2020, 12, "2020-12-23T05:00:00Z", "2023-05-12T03:59:59Z", "2023-05-08T19:02:22Z", null, 0, 0, "09000064849bcedf"], ["FDA-2020-D-1136-0040", "FDA", "FDA-2020-D-1136", "Guidance Documents Related to Coronavirus Disease 2019 (COVID\u201319);\nAvailability", "Notice", "Notice of Availability", "2020-10-16T04:00:00Z", 2020, 10, "2020-10-16T04:00:00Z", null, "2021-03-05T14:37:40Z", "2020-22968", 0, 0, "0900006484912a7f"], ["FDA-2020-D-1136-0064", "FDA", "FDA-2020-D-1136", "Resuming Normal Drug and Biologics Manufacturing Operations During the COVID-19 Public Health Emergency Guidance for Industry - \nSeptember 2020\nU.S. Department of Health and Human Services\nFood and Drug Administration\nCenter for Drug Evaluation and Research\nCenter for Biologics Evaluation and Research\nCenter for", "Other", "Guidance", "2020-09-10T04:00:00Z", 2020, 9, "2021-04-28T04:00:00Z", "2023-05-12T03:59:59Z", "2023-05-08T19:44:20Z", null, 0, 0, "0900006484abaf0f"], ["FDA-2020-D-1136-0035", "FDA", "FDA-2020-D-1136", "Manufacturing, Supply Chain, and Drug and Biological Product  Inspections During COVID-19 Public Health Emergency Questions and Answers Guidance for Industry", "Other", "Guidance", "2020-08-19T04:00:00Z", 2020, 8, "2020-08-19T04:00:00Z", "2023-11-08T04:59:59Z", "2023-05-24T20:08:59Z", null, 0, 0, "0900006484811bad"], ["FDA-2020-D-1136-0033", "FDA", "FDA-2020-D-1136", "Guidance Documents Related to Coronavirus Disease 2019; Availability", "Notice", "Notice of Availability", "2020-08-03T04:00:00Z", 2020, 8, "2020-08-03T04:00:00Z", null, "2021-03-05T14:37:26Z", "2020-16852", 0, 0, "09000064847ccc07"], ["FDA-2020-D-1136-0024", "FDA", "FDA-2020-D-1136", "Guidance Documents Related to Coronavirus Disease 2019 (COVID\u201319);\nAvailability", "Notice", "Notice of Availability", "2020-06-26T04:00:00Z", 2020, 6, "2020-06-26T04:00:00Z", null, "2021-03-05T14:37:11Z", "2020-13829", 0, 0, "090000648470facc"], ["FDA-2020-D-1136-0021", "FDA", "FDA-2020-D-1136", "Good Manufacturing Practice Considerations for Responding to COVID-19 Infection in Employees in Drug and Biological Products Manufacturing - Guidance for Industry", "Other", "Guidance", "2020-06-19T04:00:00Z", 2020, 6, "2020-06-19T04:00:00Z", "2023-05-12T03:59:59Z", "2023-05-08T19:50:01Z", null, 0, 0, "09000064846fac55"], ["FDA-2020-D-1136-0020", "FDA", "FDA-2020-D-1136", "Statistical Considerations for Clinical Trials During the COVID-19 Public Health Emergency  - Guidance for Industry", "Other", "Guidance", "2020-06-16T04:00:00Z", 2020, 6, "2020-06-16T04:00:00Z", "2023-05-12T03:59:59Z", "2023-05-09T19:04:53Z", null, 0, 0, "09000064846f4ae5"], ["FDA-2020-D-1136-0019", "FDA", "FDA-2020-D-1136", "Temporary Policy on Prescription Drug Marketing Act Requirements for Distribution of Drug Samples During the COVID-19 Public Health Emergency  - Guidance for Industry", "Other", "Guidance", "2020-06-08T04:00:00Z", 2020, 6, "2020-06-08T04:00:00Z", "2023-05-12T03:59:59Z", "2023-05-09T19:19:18Z", null, 0, 0, "09000064846d5e86"], ["FDA-2020-D-1136-0015", "FDA", "FDA-2020-D-1136", "Effects of the COVID-19 Public Health Emergency on Formal Meetings and User Fee Applications - Questions and Answers Guidance for Industry", "Other", "Guidance", "2020-05-26T04:00:00Z", 2020, 5, "2020-05-27T04:00:00Z", "2023-05-12T03:59:59Z", "2023-05-09T19:07:05Z", null, 0, 0, "09000064846b4184"], ["FDA-2020-D-1136-0014", "FDA", "FDA-2020-D-1136", "Guidance Documents Related to Coronavirus Disease 2019 (COVID\u201319);\nAvailability", "Notice", "Notice of Availability", "2020-05-26T04:00:00Z", 2020, 5, "2020-05-26T04:00:00Z", null, "2021-03-05T14:36:27Z", "2020-11238", 0, 0, "09000064846ac913"], ["FDA-2020-D-1136-0013", "FDA", "FDA-2020-D-1136", "Temporary Policy for Compounding of Certain Drugs for Hospitalized Patients by Outsourcing Facilities During the COVID-19 Public Health Emergency -  List of Drugs Used for Hospitalized Patients with COVID-19", "Other", "Background Material", "2020-05-22T04:00:00Z", 2020, 5, null, null, "2023-05-12T14:00:04Z", null, 0, 0, "090000648467120c"], ["FDA-2020-D-1136-0012", "FDA", "FDA-2020-D-1136", "COVID-19 Public Health Emergency_ General Considerations for Pre-IND_Meeting Requests for COVID-19 Related Drugs and Biological Pr-2", "Other", "Guidance", "2020-05-13T04:00:00Z", 2020, 5, "2020-05-13T04:00:00Z", "2023-05-12T03:59:59Z", "2023-05-09T19:20:08Z", null, 0, 0, "09000064845e8851"], ["FDA-2020-D-1136-0011", "FDA", "FDA-2020-D-1136", "Temporary Policy for Compounding of Certain Drugs for Hospitalized Patients by Pharmacy Compounders not Registered as Outsourcing Facilities During the COVID-19 Public Health Emergency -\nGuidance for Industry", "Other", "Guidance", "2020-05-08T04:00:00Z", 2020, 5, "2020-05-08T04:00:00Z", "2023-05-12T03:59:59Z", "2023-05-09T19:17:11Z", null, 0, 0, "0900006484591e7a"], ["FDA-2020-D-1136-0010", "FDA", "FDA-2020-D-1136", "Temporary Policy for Compounding of Certain Drugs for\nHospitalized Patients by Outsourcing Facilities During the\nCOVID-19 Public Health Emergency - Guidance for Industry", "Other", "Guidance", "2020-05-08T04:00:00Z", 2020, 5, "2020-05-08T04:00:00Z", "2023-05-12T03:59:59Z", "2024-11-12T23:19:39Z", null, 1, 0, "0900006484591e78"], ["FDA-2020-D-1136-0009", "FDA", "FDA-2020-D-1136", "Exemption and Exclusion from Certain Requirements of the Drug Supply Chain Security Act During the COVID-19 Public Health Emergency Guidance for Industry", "Other", "Guidance", "2020-04-30T04:00:00Z", 2020, 4, "2020-04-30T04:00:00Z", "2023-05-12T03:59:59Z", "2023-05-09T19:20:27Z", null, 0, 0, "090000648452228f"], ["FDA-2020-D-1136-0007", "FDA", "FDA-2020-D-1136", "Temporary Policy on Repackaging or Combining Propofol Drug Products During the COVID-19 Public Health Emergency Guidance for Industry", "Other", "Guidance", "2020-04-22T04:00:00Z", 2020, 4, "2020-04-22T04:00:00Z", null, "2024-11-06T23:33:49Z", null, 1, 0, "09000064844c296a"], ["FDA-2020-D-1136-0006", "FDA", "FDA-2020-D-1136", "Temporary Policy for Compounding of Certain Drugs for Hospitalized Patients by Pharmacy Compounders not Registered as Outsourcing Facilities During the COVID-19 Public Health Emergency Guidance for Industry", "Other", "Guidance", "2020-04-20T04:00:00Z", 2020, 4, "2020-04-20T04:00:00Z", "2023-05-12T03:59:59Z", "2023-05-09T19:16:50Z", null, 0, 0, "09000064844b9a04"], ["FDA-2020-D-1136-0004", "FDA", "FDA-2020-D-1136", "Temporary Policy for Compounding of Certain Drugs for Hospitalized Patients by Outsourcing Facilities During the COVID-19 Public Health Emergency Guidance for Industry", "Other", "Guidance", "2020-04-16T04:00:00Z", 2020, 4, "2020-04-16T04:00:00Z", "2023-05-12T03:59:59Z", "2023-05-09T19:08:50Z", null, 0, 0, "09000064844abbb7"], ["FDA-2020-D-1136-0003", "FDA", "FDA-2020-D-1136", "Temporary Policy Regarding Non-Standard PPE Practices for Sterile Compounding by Pharmacy Compounders not Registered as Outsourcing Facilities During the COVID-19 Public Health Emergency", "Other", "Guidance", "2020-04-10T04:00:00Z", 2020, 4, "2020-04-10T04:00:00Z", "2023-05-12T03:59:59Z", "2023-05-09T19:18:35Z", null, 0, 0, "0900006484499af1"], ["FDA-2020-D-1136-0002", "FDA", "FDA-2020-D-1136", "Policy for the Temporary Use of Portable Cryogenic Containers Not in Compliance With 21 CFR 211.94(e)(1) For Oxygen and Nitrogen During the COVID-19 Public Health Emergency Guidance for Industry", "Other", "Guidance", "2020-04-09T04:00:00Z", 2020, 4, "2020-04-09T04:00:00Z", "2023-11-08T04:59:59Z", "2023-05-24T20:07:17Z", null, 0, 0, "090000648449747d"], ["FDA-2020-D-1136-0001", "FDA", "FDA-2020-D-1136", "Process for Making Available Guidance Documents Related to Coronavirus Disease 2019", "Notice", "Announcement", "2020-03-25T04:00:00Z", 2020, 3, "2020-03-25T04:00:00Z", null, "2021-03-05T14:35:54Z", "2020-06222", 0, 0, "090000648446b620"]], "truncated": false, "filtered_table_rows_count": 41, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2020-D-1136"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2020-D-1136", "results": [{"value": "FDA", "label": "FDA", "count": 41, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1136&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2020-D-1136", "results": [{"value": "Other", "label": "Other", "count": 26, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1136&document_type=Other", "selected": false}, {"value": "Notice", "label": "Notice", "count": 15, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1136&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2020-D-1136", "results": [{"value": 2020, "label": 2020, "count": 22, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1136&posted_year=2020", "selected": false}, {"value": 2021, "label": 2021, "count": 12, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1136&posted_year=2021", "selected": false}, {"value": 2023, "label": 2023, "count": 5, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1136&posted_year=2023", "selected": false}, {"value": 2022, "label": 2022, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1136&posted_year=2022", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1136&_facet=subtype"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1136&_facet=posted_month"}, {"name": "comment_end_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1136&_facet=comment_end_date"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1136&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1136&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1136&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1136&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1136&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 343.59886206220835, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}